Barrier Therapeutics, Inc. (NASDAQ: BTRX), a pharmaceutical company developing and commercializing products in the field of dermatology, today announced that Geert Cauwenbergh, Ph.D., Chairman and Chief Executive Officer is scheduled to participate in the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference.
